Klogrel Tablet

Klogrel Tablet – Critical Anti-Platelet Protection

Klogrel is a vital anti-platelet medication containing Clopidogrel, designed for the secondary prevention of serious cardiovascular events. It is primarily indicated for patients at high risk of atherothrombotic complications, such as those with a recent history of heart attack, stroke, or established peripheral arterial disease. Klogrel works by preventing platelets in the blood from sticking together and forming harmful clots within the vessels. Preventing these clots is the most important factor in reducing the risk of a recurrent heart attack or stroke. It is also a standard therapy for patients who have recently had stents placed in their heart or other arteries to ensure they remain open. The medication provides continuous protection and is typically taken once daily as part of a long-term cardiovascular health plan. Patients on Klogrel should be under regular medical supervision and informed that they may bruise more easily or take longer to stop bleeding while on therapy. It serves as a cornerstone in post-event care, significantly improving the survival and long-term outcomes for patients with chronic cardiovascular disease.

• Indicated for the prevention of atherothrombotic complications.
• Anti-platelet therapy for post-heart attack and post-stroke care.
• Critical for patients with stents or peripheral arterial disease.
• Available as: Tablet 75mg.